Literature DB >> 16800724

A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.

Ake Lundwall1, Vimla Band, Michael Blaber, Judith A Clements, Yves Courty, Eleftherios P Diamandis, Hans Fritz, Hans Lilja, Johan Malm, Lois J Maltais, A Yvonne Olsson, Constantina Petraki, Andreas Scorilas, Georgia Sotiropoulou, Ulf-Håkan Stenman, Carsten Stephan, Maroulio Talieri, George M Yousef.   

Abstract

The human kallikrein locus on chromosome 19q13.3-13.4 contains kallikrein 1--the tissue kallikrein--and 14 related serine proteases. Recent investigations into their function and evolution have indicated that the present nomenclature for these proteins is inadequate or insufficient. Here we present a new nomenclature in which proteins without proven kininogenase activity are denoted kallikrein-related peptidase. Names are also given to the unique rodent proteins that are closely related to kallikrein 1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800724     DOI: 10.1515/BC.2006.082

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  26 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

Authors:  Maja Radulovic; Hyesook Yoon; Nadya Larson; Jianmin Wu; Rachel Linbo; Joshua E Burda; Eleftherios P Diamandis; Sachiko I Blaber; Michael Blaber; Michael G Fehlings; Isobel A Scarisbrick
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

3.  Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group.

Authors:  Guyan Liang; Xin Chen; Suzanne Aldous; Su-Fen Pu; Shujaath Mehdi; Elaine Powers; Andrew Giovanni; Sathapana Kongsamut; Tianhui Xia; Ying Zhang; Rachel Wang; Zhongli Gao; Gregory Merriman; Larry R McLean; Isabelle Morize
Journal:  ACS Med Chem Lett       Date:  2012-01-11       Impact factor: 4.345

Review 4.  Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.

Authors:  Daniel L J Thorek; Michael J Evans; Sigrid V Carlsson; David Ulmert; Hans Lilja
Journal:  Thromb Haemost       Date:  2013-08-01       Impact factor: 5.249

5.  Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma.

Authors:  Rong Jiang; Zonggao Shi; Jeffrey J Johnson; Yueying Liu; M Sharon Stack
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

6.  Stability of [-2]Pro-PSA in whole blood and serum: analysis for optimal measurement conditions.

Authors:  Tsukasa Igawa; Kosuke Takehara; Toru Onita; Kazuto Ito; Hideki Sakai
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

7.  Impaired male fertility and atrophy of seminiferous tubules caused by haploinsufficiency for Foxa3.

Authors:  Rüdiger Behr; Sara D Sackett; Irina M Bochkis; Phillip Phuc Le; Klaus H Kaestner
Journal:  Dev Biol       Date:  2007-04-05       Impact factor: 3.582

Review 8.  Functions of KLK4 and MMP-20 in dental enamel formation.

Authors:  Yuhe Lu; Petros Papagerakis; Yasuo Yamakoshi; Jan C-C Hu; John D Bartlett; James P Simmer
Journal:  Biol Chem       Date:  2008-06       Impact factor: 3.915

9.  A completed KLK activome profile: investigation of activation profiles of KLK9, 10, and 15.

Authors:  Hyesook Yoon; Sachiko I Blaber; Mekdes Debela; Peter Goettig; Isobel A Scarisbrick; Michael Blaber
Journal:  Biol Chem       Date:  2009-04       Impact factor: 3.915

10.  Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration.

Authors:  Isobel A Scarisbrick; Rachel Linbo; Alexander G Vandell; Mark Keegan; Sachiko I Blaber; Michael Blaber; Diane Sneve; Claudia F Lucchinetti; Moses Rodriguez; Eleftherios P Diamandis
Journal:  Biol Chem       Date:  2008-06       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.